TGT
50
3
HON
64
4
NRG
37
-2
K
56
3
ROST
66
4
FDX
40
4
PAYX
54
9
EQR
39
2
KSS
42
3
IFF
45
-2
VMC
44
2
FAST
42
-2
SE
58
-2
PVH
59
-3
CA
32
3
MKC
51
-2
PHM
50
2
IVZ
50
2
TJX
59
5
SRE
45
-2
TGT
50
3
HON
64
4
NRG
37
-2
K
56
3
ROST
66
4
FDX
40
4
PAYX
54
9
EQR
39
2
KSS
42
3
IFF
45
-2
VMC
44
2
FAST
42
-2
SE
58
-2
PVH
59
-3
CA
32
3
MKC
51
-2
PHM
50
2
IVZ
50
2
TJX
59
5
SRE
45
-2
Financhill
Back

Nuveen Municipal Credit Income Fund Vs. Aligos Therapeutics Industry Stock Comparison

Sell
30

NZF
Nuveen Municipal Credit Income Fund

Last Price:
$12.11
Seasonality Move:
1.2%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
30
Nuveen Municipal Credit Income Fund (NZF) is a Sell

Is Nuveen Municipal Credit Income Fund a Buy, Sell or Hold?

  • The current Nuveen Municipal Credit Income Fund [NZF] share price is $12.28. The Score for NZF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NZF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NZF Stock Price Chart

What is Nuveen Municipal Credit Income Fund's stock price today?

  • The Nuveen Municipal Credit Income Fund share price today is $12.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NZF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NZF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 34.27 Sell
Chaikin Money Flow: 1143400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.41 - 13.01) Sell
Bollinger Bands (100): (12.56 - 12.98) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

NZF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.34 Sell
20-day SMA: 12.71 Sell
50-day SMA: 12.67 Sell
200-day SMA: 12.45 Sell
8-day EMA: 12.36 Sell
20-day EMA: 12.55 Sell
50-day EMA: 12.67 Sell
200-day EMA: 12.46 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Nuveen Municipal Credit Income Fund Earnings Growth & NZF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Nuveen Municipal Credit Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):